Insulin Resistance and Propolis in Polycystic Ovary Syndrome (PCOS) Model Rats
Article Sidebar
Main Article Content
Abstract
Administering propolis delays the liver's release into the bloodstream and stimulates insulin-sensitive glucose transporters.. The purpose of this study is to assess propolis' impact on insulin resistance in mice that are PCOS model users. The control group design was restricted to post-test in laboratory experimental research. Twenty-five female Wistar rats, three months old, weighing between 100 and 130 grams, were utilised as research subjects in this study. The rats were in good health, had normal activity levels, had normal vaginal swabs, were not pregnant, and had no anatomical abnormalities. Groups K1 (negative control), K2 (positive control PCOS), P1 (PCOS + propolis 50 mg/kgBW), P2 (PCOS + propolis 100 mg/kgBW), and P3 (PCOS + propolis 200 mg/kgBW) were the five groups into which the subjects were split. kgBB). After a 21-day High Fat, High Fructose (HFHF) diet and intramuscular testosterone propionate (1.8 mg/kgBW) injection, the treatment group received propolis interventions at doses of 50 mg/kgBW (P1), 100 mg/kgBW (P2), and 200 mg/kgBB (P3) for 14 days. On the 36th day GDP, insulin, HOMA-IR, and HOMA-B values were measured. The data obtained were analysed with One-way ANOVA and the Kruskal-Wallis test and p<0.001 values were regarded as statistically significant. Propolis treatment significantly (p<0.001) lowers the levels of FBS and HOMA-IR (p<0.05), raises insulin levels and dramatically (p<0.001) raises HOMA-β values. The highest effective dose of propolis that significantly reduced insulin resistance in PCOS mice was 100 mg/kgBW. The study concluded that in PCOS model mice, propolis significantly reduced insulin resistance.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Rothenberg SS, Beverley R, Barnard E, Baradaran-Shoraka M, Sanfilippo JS. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol. 2018;48:103–114.
Jeanes YM, Reeves S. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev. 2017;30(1):97–105.
Alan M, Gurlek B, Yilmaz A, Aksit M, Aslanipour B, Gulhan I, Mehmet C, Taner CE. Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(3):220–223.
Tarry-Adkins JL, Grant ID, Ozanne SE, Reynolds RM, Aiken CE. Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis. Diabetes Ther. 2021;12(7):1901–1914.
Shafriani NR. Pengaruh Propolis Terhadap Il-6 Pada Diabetes Melitus Tipe 2: A Literature Review. Herb-Med J. 2021;4(3):57.
Anvarifard P, Anbari M, Ostadrahimi A, Ardalan M, Ghoreishi Z. A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review. Nutr Metab. 2022;19(1):6.
Sameni HR, Ramhormozi P, Bandegi AR, Taherian AA, Mirmohammadkhani M, Safari M. Effects of ethanol extract of propolis on histopathological changes and anti‐oxidant defense of kidney in a rat model for type 1 diabetes mellitus. J Diabetes Investig. 2016;7(4):506–513.
Pahlavani N, Malekahmadi M, Firouzi S, Rostami D, Sedaghat A, Moghaddam AB, et al. Molecular and cellular mechanisms of the effects of Propolis in inflammation, oxidative stress and glycemic control in chronic diseases. Nutr Metab. 2020;17(1):65.
Ezeh U, Chen IYD, Chen YH, Azziz R. Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function. J Clin Endocrinol Metab. 2020;105(7):e2408–2420.
Chien YH, Yu YH, Chen YW. Taiwanese green propolis ameliorates metabolic syndrome via remodelling of white adipose tissue and modulation of gut microbiota in diet-induced obese mice. Biomed Pharmacother. 2023;160:114386.
Fukuda T, Fukui M, Tanaka M, Senmaru T, Iwase H, Yamazaki M, Aoi W, Inui T, Nakamura N, Marunaka Y.. Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study. Biomed Rep. 2015;3(3):355–360.
Braakhuis A. Evidence on the Health Benefits of Supplemental Propolis. Nutrients. 2019;11(11):2705.
Nikbaf-Shandiz M, Tutunchi H, Khoshbaten M, Nazari Bonab H, Ebrahimi-Mameghani M. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation. Food Funct. 2022;13(22):11568–11578.
Touzani S, Al-Waili N, Imtara H, Aboulghazi A. Arbutus Unedo Honey and Propolis Ameliorate Acute Kidney Injury, Acute Liver Injury, and Proteinuria via Hypoglycemic and Antioxidant Activity in Streptozotocin-Treated Rats. Cell Physiol Biochem. 2022;56(1):66–81.
Nna VU, Abu Bakar AB, Md Lazin MRML, Mohamed M. Antioxidant, anti-inflammatory and synergistic anti-hyperglycemic effects of Malaysian propolis and metformin in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2018;120:305–320.
Mujica V, Orrego R, Pérez J, Romero P, Ovalle P, Zúñiga-Hernández J, Arredondo M, Leiva E. The Role of Propolis in Oxidative Stress and Lipid Metabolism: A Randomized Controlled Trial. Evid Based Complement Alternat Med. 2017;2017:1–11.
Sapmaz T, Sevgin K, Topkaraoglu S, Tekayev M, Gumuskaya F, Efendic F, Pence ME, Aktas S, Hekimoglu G, Irkorucu O. Propolis protects ovarian follicular reserve and maintains the ovary against polycystic ovary syndrome (PCOS) by attenuating degeneration of zona pellucida and fibrous tissue. Biochem Biophys Res Commun. 2022;636:97–103.